Lipid peroxidation markers in coronary artery disease patients with possible vascular mild cognitive impairment

Manuscript Number: 

16-1248R2

Author(s): 
Alex Adibfar, Ana Andreazza, Nathan Herrmann, Krista L. Lanctôt, Paul I. Oh, Mahwesh Saleem, Ivonne Suridjan

Disclosures

Alex Adibfar

  • Nothing to Disclose

Ana Andreazza

  • Nothing to Disclose

Nathan Herrmann

  • Consulting Fees:
    Astellas, Merck, Lilly
    Grants
    • Agency: 
      Lundbeck
      Dates: 
      2014-2016
    • Agency: 
      Axovant
      Dates: 
      2015-2017

Krista L. Lanctôt

  • Consulting Fees:
    Consultation fees from Lundbeck, Otsuka and Merck.
    Grants
    • Agency: 
      AbbVie Canada
      Dates: 
      Sep 2016 to Aug 2017
    • Agency: 
      Lundbeck Canada Inc
      Dates: 
      Jan 2014 – Dec 2016
    • Agency: 
      Elan Pharma International Ltd.
      Dates: 
      Apr 2013 – Dec 2015
    • Agency: 
      Novartis Canada
      Dates: 
      Dec 2014 – May 2015
    • Agency: 
      F. Hoffman-La Roche Ltd.
      Dates: 
      Dec 2012 – Dec 2015

Paul I. Oh

  • Nothing to Disclose

Mahwesh Saleem

  • Nothing to Disclose

Ivonne Suridjan

  • Nothing to Disclose